Zosano Pharma

Fremont,  CA 
United States
  • Booth: 1604

Zosano Pharma is a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients using our proprietary Adhesive Dermally-Applied Microarray, or ADAM technology. In 2017, we announced positive results from our pivotal efficacy trial that evaluated Qtrypta (M207), which is our proprietary formulation of zolmitriptan delivered via our ADAM technology, as an acute treatment for migraine. 

 Additional Info

First Time Exhibitor
For Technical Support with this webpage, please contact support.